Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model
2022 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-022-06953-7
J
Jim Kaberna
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
20
Citations
1
h-index
1
i10-index
Jim Kaberna is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: T-cell and B-cell Immunology & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 1, co-authored 1 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat